Syrs earnings report
Web1 day ago · Syros Pharmaceuticals (SYRS) (Real Time Quote from BATS) $2.73 USD +0.11 (4.20%) Updated Apr 13, 2024 01:37 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value F Growth D... WebMar 15, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.61 per share a year ago.
Syrs earnings report
Did you know?
WebMar 1, 2024 · SYRS. is set to give its latest quarterly earnings report on Thursday, 2024-03-02. Here's what investors need to know before the announcement. Analysts estimate that Syros Pharmaceuticals will ... WebPut Open Interest: The total open interest of puts for the expiration date. Call Open Interest: The total open interest of calls for the expiration date. Put/Call Open Interest Ratio: The total put open interest divided by the total call open interest for the expiration date. Implied Volatility: The average implied volatility of the calls and ...
WebSyros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates Mar. 2, 2024 at 9:35 a.m. ET on Zacks.com Syros Pharmaceuticals's Earnings Outlook Mar. 1, 2024 at 1:01 p.m. ET on... WebApr 15, 2024 · The firm has a market capitalization of $54.81 million, a price-to-earnings ratio of -0.21 and a beta of 1.67. Syros Pharmaceuticals has a fifty-two week low of $2.42 and a fifty-two week high of ...
WebSyros Pharmaceuticals, Inc. (SYRS) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed Dow Futures Nasdaq Futures Russell 2000 Futures (+0.25%) Crude Oil Gold Syros... WebBased on 5 Wall Street analysts offering 12 month price targets for Syros Pharmaceuticals in the last 3 months. The average price target is $24.00 with a high forecast of $60.00 and a low forecast of $13.00. The average price target represents a 858.08% change from the last price of $2.51. Highest Price Target $60.00. Average Price Target $24.00.
WebSyros Pharmaceuticals (SYRS) Earnings Date & Reports 641 Followers Portfolio Earnings Data Report Date May 10, 2024 Not Confirmed Period Ending 2024 (Q1) Consensus EPS …
WebSyros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. emma watson years activeWebMar 2, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. emma watson yellow wiggleWebNov 14, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $2.41 per share versus the Zacks Consensus Estimate of a loss of $3.91. This compares to loss of $4.10 per share a year ago.... dragunity pojo threadWebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the... SYRS : 2.51 (-2.15%) VRDN : 25.41 (+1.97%) emma watson y leo robintonWebApr 6, 2024 · Syros Pharmaceuticals reports Q4 EPS (17c), consensus ($1.35) Reports Q4 revenue ($754,000), consensus $3.72M. "In 2024, we advanced our efforts to develop new … dragunity otkWebApr 15, 2024 · NASDAQ SYRS opened at $2.70 on Friday. The stock has a market capitalization of $54.81 million, a PE ratio of -0.21 and a beta of 1.67. The business has a 50 day simple moving average of $3.39 and ... emma watson y daniel radcliffe sonWeb26 rows · Apr 8, 2024 · Syros Pharmaceuticals last posted its quarterly earnings results on March 2nd, 2024. The ... dragunity ran ep7